<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04687917</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA052294</org_study_id>
    <secondary_id>R01DA052294</secondary_id>
    <nct_id>NCT04687917</nct_id>
  </id_info>
  <brief_title>The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project</brief_title>
  <official_title>The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RTI International</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>RTI International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An experiment to test the effectiveness of providing monetary bonuses to staff for achieving&#xD;
      pre-defined performance targets regarding the implementation of a motivational&#xD;
      interviewing-based brief intervention for substance use.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cluster-randomized type 3 hybrid trial with HIV service organizations across the United&#xD;
      States. The primary aims is to test the effectiveness of an innovative pay-for-performance&#xD;
      (P4P) strategy for improving the implementation of a motivational interviewing-based brief&#xD;
      intervention for substance use.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Cluster-randomized trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implementation consistency</measure>
    <time_frame>Assessed at the end of month 12</time_frame>
    <description>The cumulative number of brief interventions that each staff participant implemented during the implementation phase.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implementation quality</measure>
    <time_frame>Assessed at the end of month 12</time_frame>
    <description>The cumulative sum quality score that each staff participant demonstrated during the implementation phase.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days using primary substance</measure>
    <time_frame>Assessed at 4-weeks from the baseline assessment</time_frame>
    <description>The number of days clients used their primary substance (i.e., the substance the client identified a willingness to talk about during the MIBI) during the past 28 day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7)</measure>
    <time_frame>Assessed at 4-weeks from the baseline assessment</time_frame>
    <description>The sum of the 7 items including in the Generalized Anxiety Disorder 7-item (GAD-7), which ranges from 0 to 21 and where higher scores mean a worse outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1980</enrollment>
  <condition>Substance Use</condition>
  <arm_group>
    <arm_group_label>Training, Feedback, Consultation, and Facilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A multilevel implementation strategy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training, Feedback, Consultation, Facilitation, and P4P</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An enhanced version of the multilevel implementation strategy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The facilitation, training, feedback, and consultation (FTFC) Strategy</intervention_name>
    <description>A multilevel implementation strategy that includes team-focused facilitation, as well as staff-focused training, feedback, and consultation</description>
    <arm_group_label>Training, Feedback, Consultation, and Facilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The facilitation, training, feedback, consultation, and pay-for-performance (FTFC+PFP) Strategy</intervention_name>
    <description>A multilevel implementation strategy that includes team-focused facilitation, as well as staff-focused training, feedback, consultation, and pay-for-performance.</description>
    <arm_group_label>Training, Feedback, Consultation, Facilitation, and P4P</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria for staff participants:&#xD;
&#xD;
               -  18+ years of age&#xD;
&#xD;
        Inclusion criteria for client participants:&#xD;
&#xD;
          -  18+ years of age&#xD;
&#xD;
          -  Diagnosed with HIV&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria for staff participants:&#xD;
&#xD;
               -  None&#xD;
&#xD;
        Exclusion criteria for client participants:&#xD;
&#xD;
        * None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alyssa Toro</last_name>
    <role>Study Director</role>
    <affiliation>RTI International</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bryan R. Garner, PhD</last_name>
    <phone>919-597-5159</phone>
    <phone_ext>25159</phone_ext>
    <email>bgarner@rti.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>RTI International</name>
      <address>
        <city>Research Triangle Park</city>
        <state>North Carolina</state>
        <zip>27709</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan R. Garner, Phd</last_name>
      <phone>919-597-5159</phone>
      <phone_ext>25159</phone_ext>
      <email>bgarner@rti.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 18, 2020</study_first_submitted>
  <study_first_submitted_qc>December 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RTI International</investigator_affiliation>
    <investigator_full_name>Bryan R. Garner</investigator_full_name>
    <investigator_title>Senior Implementation Research Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After deidentification, all of the individual participant data collected during the trial.</ipd_description>
    <ipd_time_frame>After study completion</ipd_time_frame>
    <ipd_access_criteria>Anyone who wishes to access the data.</ipd_access_criteria>
    <ipd_url>https://www.icpsr.umich.edu/web/pages/NAHDAP/index.html</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

